MACH7 TECHNOLOGIES LIMITED — Board/Management Information 2022

Dec 28, 2022

ASX Announcement

==> picture [104 x 26] intentionally omitted <==

29 December 2022

CFO Transition

Mach7 Technologies Limited (“Mach7” or the “Company”) (ASX:M7T), a company specialising in innovative medical imaging software solutions, announces that Steve Parkes, Chief Financial Officer (CFO) will leave Mach7 on 1 January 2023 to pursue other opportunities. Dyan O’Herne, Mach7’s current Global Controller, has been appointed to the role of Interim CFO from that date.

Ms. O’Herne has been with Mach7 for seven years in financial controller roles and has a deep knowledge of the Company’s finances, operations, and culture. She is a Chartered Accountant with more than 20 years’ experience in senior finance roles including with Aon Insurance Managers and PricewaterhouseCoopers immediately prior to joining Mach7.

CEO and Managing Director of Mach7, Mike Lampron said: “ I’d like to thank Steve for his contribution to Mach7, he leaves us in good shape having implemented a new accounting system and overseen our share registry transition during his tenure. I am also pleased to have Dyan step into this role. Her long tenure at Mach7 and thorough knowledge of the business will continue to be a great asset to the Company and provide continuity for our finance function. ”

Released on authority of the Board by:

Mike Lampron Chief Executive Officer

For more information, contact:

Investor Relations: Rebecca Thompson +61 (0) 416 079 329 rebecca.thompson@mach7t.com

About Mach7 Technologies:

Mach7 Technologies (ASX:M7T) is a medical imaging systems provider that develops innovative image management and viewing solutions for healthcare organisations. The core of these offerings is the Mach7 Enterprise Imaging Solution, encompassing Enterprise Data Management, Enterprise Diagnostic Viewing and Diagnostic Workflow applications. Mach7’s Enterprise Data Management solution, consisting of a powerful Vendor Neutral Archive (VNA) and data administration tools, allows for the fast storage, access, retrieval and viewing of images across a healthcare network with connectivity to the Cloud. In July 2020, Mach7 acquired Client Outlook and the eUnity Enterprise Diagnostic Viewing technology to augment Mach7’s Enterprise Data Management and Diagnostic Workflow applications. eUnity is a zero-footprint, FDA-approved, image viewing solution that makes images accessible on any workstation. This offers healthcare professionals consolidated access to all patient images and data, ensuring clinical staff have timely access to the right information to diagnose and treat patients. Uniquely, the company also gives customers independence to deploy its solutions either on a component basis or in a unified comprehensive platform. Mach7 has built a global network of diverse customers that range from expansive Integrated Delivery Networks, National Health Systems, medical research facilities, and large academic medical institutions to regional community hospitals, private radiology practices, and independent provider groups. Visit Mach7t.com.

==> picture [150 x 11] intentionally omitted <==

==> picture [150 x 12] intentionally omitted <==

==> picture [150 x 11] intentionally omitted <==

==> picture [150 x 12] intentionally omitted <==

==> picture [150 x 11] intentionally omitted <==

Mach7 Technologies Limited (ASX:M7T) ABN: 26 007 817 192 Registered Office: Level 4, 96 – 100 Albert Road, South Melbourne, VIC 3205 T: 03 9692 7222 www.mach7t.com